SPI-339

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameSPI-339
Drug Alias NameNEO-339
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCognitive Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpectrum Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpectrum Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityCognitive Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A